株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

持続的腎代替療法装置の世界市場:2018年~2022年

Global Continuous Renal Replacement Therapy Devices Market 2018-2022

発行 TechNavio (Infiniti Research Ltd.) 商品コード 785642
出版日 ページ情報 英文 129 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.78円で換算しております。
Back to Top
持続的腎代替療法装置の世界市場:2018年~2022年 Global Continuous Renal Replacement Therapy Devices Market 2018-2022
出版日: 2018年12月21日 ページ情報: 英文 129 Pages
概要

腎代替療法は急性腎不全の治療に大きな影響を及ぼします。腎代替療法のタイミング、治療モダリティの選択、治療の強度が急性腎不全治療における腎代替療法の効果を決める最重要因子です。同市場は、2022年まで7%のCAGR (複合年間成長率) で拡大すると予測されています。

当レポートでは、世界の持続的腎代替療法装置市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入するベンダーのプロファイルについてまとめています。

第1章 エグゼクティブサマリー

第2章 レポートの範囲

第3章 調査方法

第4章 市況

  • 市場のエコシステム
  • 市場の特長
  • 市場セグメンテーション分析

第5章 市場規模

  • 市場の定義
  • 市場規模:2017年
  • 市場規模と予測:2017~2022年

第6章 ファイブフォース分析

第7章 モダリティ別市場セグメンテーション

  • 市場セグメンテーション
  • 比較
  • 持続的静脈-静脈血液濾過(CVVH)
  • 持続的静静脈血液ろ過透析(CVVHDF)
  • 持続的静静脈血液透析(CVVHD)
  • 持続的限外ろ過(SCUF)
  • 市場の機会

第8章 製品別市場セグメンテーション

  • セグメンテーション
  • 比較
  • 消耗品
  • システム
  • 市場の機会

第9章 顧客動向

第10章 地域別動向

  • 地域別セグメンテーション
  • 比較
  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域
  • 主要国
  • 市場の機会

第11章 意思決定の枠組み

第12章 促進因子と課題

第13章 市場動向

第14章 ベンダー環境

第15章 ベンダー分析

  • 網羅されるベンダー
  • ベンダー分類
  • 市場ポジショニング
  • A旭化成メディカル株式会社
  • B. Braun Melsungen
  • Baxter
  • Fresenius Medical Care
  • Medtronic

第16章 付録

第17章 Technavioについて

図表
  • Exhibit 01: Global urology devices market
  • Exhibit 02: Global urology devices market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Modality - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by modality
  • Exhibit 20: Continuous venovenous hemofiltration (CVVH) - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Continuous venovenous hemofiltration (CVVH) - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Continuous venovenous hemodiafiltration (CVVHDF) - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Continuous venovenous hemodiafiltration (CVVHDF) - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Continuous venovenous hemodialysis (CVVHD) - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 25: Continuous venovenous hemodialysis (CVVHD) - Year-over-year growth 2018-2022 (%)
  • Exhibit 26: Slow continuous ultrafiltration (SCUF) - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 27: Slow continuous ultrafiltration (SCUF) - Year-over-year growth 2018-2022 (%)
  • Exhibit 28: Market opportunity by modality
  • Exhibit 29: Product - Market share 2017-2022 (%)
  • Exhibit 30: Comparison by product
  • Exhibit 31: Consumables - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 32: Consumables - Year-over-year growth 2018-2022 (%)
  • Exhibit 33: Systems - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 34: Systems - Year-over-year growth 2018-2022 (%)
  • Exhibit 35: Market opportunity by product
  • Exhibit 36: Customer landscape
  • Exhibit 37: Global - Market share by geography 2017-2022 (%)
  • Exhibit 38: Regional comparison
  • Exhibit 39: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 40: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 41: Top three countries in EMEA
  • Exhibit 42: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 43: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 44: Top three countries in Americas
  • Exhibit 45: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 46: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 47: Top three countries in APAC
  • Exhibit 48: Market opportunity
  • Exhibit 49: Percentage of aging population 65 years and above (%)
  • Exhibit 50: Vendor landscape
  • Exhibit 51: Landscape disruption
  • Exhibit 52: Vendors covered
  • Exhibit 53: Vendor classification
  • Exhibit 54: Market positioning of vendors
  • Exhibit 55: Asahi Kasei Medical - Overview
  • Exhibit 56: Asahi Kasei Medical - Products category
  • Exhibit 57: Asahi Kasei Group - Geographic focus
  • Exhibit 58: Asahi Kasei Medical - Category focus
  • Exhibit 59: Asahi Kasei Medical - Key offerings
  • Exhibit 60: Asahi Kasei Medical - Key customers
  • Exhibit 61: B. Braun Melsungen - Overview
  • Exhibit 62: B. Braun Melsungen - Business segments
  • Exhibit 63: B. Braun Melsungen - Organizational developments
  • Exhibit 64: B. Braun Melsungen - Geographic focus
  • Exhibit 65: B. Braun Melsungen - Segment focus
  • Exhibit 66: B. Braun Melsungen - Key offerings
  • Exhibit 67: B. Braun Melsungen - Key customers
  • Exhibit 68: Baxter - Overview
  • Exhibit 69: Baxter - Business segments
  • Exhibit 70: Baxter - Organizational developments
  • Exhibit 71: Baxter - Geographic focus
  • Exhibit 72: Baxter - Segment focus
  • Exhibit 73: Baxter - Key offerings
  • Exhibit 74: Baxter - Key customers
  • Exhibit 75: Fresenius Medical Care - Overview
  • Exhibit 76: Fresenius Medical Care - Business segments
  • Exhibit 77: Fresenius Medical Care - Organizational developments
  • Exhibit 78: Fresenius Medical Care - Geographic focus
  • Exhibit 79: Fresenius Medical Care - Segment focus
  • Exhibit 80: Fresenius Medical Care - Key offerings
  • Exhibit 81: Fresenius Medical Care - Key customers
  • Exhibit 82: Medtronic - Overview
  • Exhibit 83: Medtronic - Business segments
  • Exhibit 84: Medtronic - Organizational developments
  • Exhibit 85: Medtronic - Geographic focus
  • Exhibit 86: Medtronic - Segment focus
  • Exhibit 87: Medtronic - Key offerings
  • Exhibit 88: Medtronic - Key customers
目次
Product Code: IRTNTR23363

About this market

The incidence of AKIs in ICU patients is increasing, and severe cases of AKI are mostly treated through renal replacement therapy (RRT). CRRT is the most preferred therapy in ICU patients suffering from AKI due to their hemodynamic instability. Acute renal failures are common and can lead to serious complications in severely ill patients. The use of renal replacement therapy has a major impact in terms of treating acute renal failure. The timing of the initiation of the renal replacement therapy, the selection of the specific modality of the therapy, and the intensity of the therapy are the most important factors in determining the effectiveness of renal replacement therapy in treating acute renal failure. Technavio's analysts have predicted that the continuous renal replacement therapy devices market will register a CAGR of over 7% by 2022.

Market Overview

Advantages of CRRT over IRRT

CRRT offers some key clinical advantages over intermittent blood purification techniques such as intermittent hemodialysis (IHD), sustained low-efficiency daily dialysis (SLEDD), and peritoneal dialysis (PD).

Limitations of and complications involved in CRRT

Technical limitations such as the interaction between the technician or medical staff and the machine inhibit the quality of real-time data analytics carried out. These limitations apply both to the way in which patients are clinically managed and how the technology is used.

For the detailed list of factors that will drive and challenge the growth of the continuous renal replacement therapy devices market during the 2018-2022, view our report.

Competitive Landscape

The continuous renal replacement therapy devices market is moderately concentrated with companies. the increasing competition in mature markets, will further trigger CRRT device manufacturers to focus on the emerging markets during the forecast period. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY MODALITY

  • Segmentation by modality
  • Comparison by modality
  • Global continuous venovenous hemofiltration (CVVH) market
  • Global continuous venovenous hemodiafiltration (CVVHDF) market
  • Global continuous venovenous hemodialysis (CVVHD) market
  • Global slow continuous ultrafiltration (SCUF) market
  • Market opportunity by modality

PART 08: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Global consumables market
  • Global systems market
  • Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • CRRT devices market in EMEA
  • CRRT devices market in Americas
  • CRRT devices market in APAC
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Opportunities in emerging markets
  • Focus on miniaturization and wearable technology and that for infant and
  • pediatric applications
  • Technological advances in CRRT

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Asahi Kasei Medical (a subsidiary of Asahi Kasei Group)
  • B. Braun Melsungen
  • Baxter
  • Fresenius Medical Care
  • Medtronic

PART 16: APPENDIX

  • List of abbreviations

PART 17: EXPLORE TECHNAVIO

Back to Top